Article
Personalized and targeted therapy of esophageal squamous cell carcinoma: an update
11 Jul 2016
Abstract excerpt
Esophageal squamous cell carcinoma (ESCC) is a deadly disease that requires extensive research. In this review, we update recent progress in the research area of targeted therapy for ESCC. SOX2 and its associated proteins (e.g., ΔNP63α), which regulate lineage survival of ESCC cells, are proposed as therapeutic targets. It is believed that targeting the lineage-survival mechanism may be more effective than...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
